This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2007-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2014
Title: The Innovations of Paul J Hoogestraat: Revolutionizing Medicinal Chemistry
Introduction: Paul J Hoogestraat, a talented inventor based in Indianapolis, IN, has made significant contributions to the field of medicinal chemistry through his groundbreaking inventions. With a total of 3 patents to his name, Hoogestraat's work at Eli Lilly and Company has been instrumental in developing innovative pharmaceutical solutions.
Latest Patents:
1. Aldosterone Synthase Inhibitor: Hoogestraat's invention of aldosterone synthase inhibitors has paved the way for novel pharmaceutical preparations aimed at treating a range of conditions. The inhibitors not only demonstrate promise in targeting specific pathways but also offer new methods for treatment.
2. CB1 Modulator Compounds: His discovery of CB1 modulator compounds represents a major breakthrough in the treatment of diseases mediated by the CB1 receptor. These compounds show potential in addressing a myriad of conditions such as psychosis, memory deficits, epilepsy, and substance abuse disorders, among others.
Career Highlights: With a sharp focus on research and development, Hoogestraat has excelled at Eli Lilly and Company, consistently pushing the boundaries of medicinal chemistry. His commitment to innovation and scientific exploration has not only led to successful patents but has also contributed to the advancement of pharmaceutical science.
Collaborations: Collaborating with esteemed coworkers such as Jennifer Rebecca Allen and Albert Kudzovi Amegadzie, Hoogestraat has fostered a culture of innovation and excellence at Eli Lilly and Company. Together, they have worked towards creating solutions that address unmet medical needs and enhance patient outcomes.
Conclusion: Paul J Hoogestraat's inventive spirit and relentless dedication to advancing medicinal chemistry underscore his position as a pioneering figure in the field. His patents stand as a testament to his innovative prowess and commitment to revolutionizing healthcare. Through collaborations and career milestones, Hoogestraat continues to shape the landscape of pharmaceutical innovation, leaving an indelible mark on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile